Evaluation of plasma neurofilament light chain levels in patients with spinal muscular atrophy treated with onasemnogene abeparvovec: association with motor outcomes
Background: Spinal muscular atrophy (SMA) is an autosomal recessive disease of the lower motor neurons characterized by progressive hypotonia and weakness. Onasemnogene abeparvovec is a gene replacement therapy that restores SMN protein levels in motor neurons. Neurofilament light chain (NfL) is a biomarker of neuroaxo...